Hyperphosphatemia Drugs Market Size By Application, Industry Analysis Report, Regional Outlook (North America, Europe, Asia Pacific, Middle East & Africa, And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2030 (Recession Impact Analysis)
ID : MRU_
4960 | Date :
Jan, 2023 | Pages :
186 | Region : Global |
Publisher : 99 Strategy
hosphorus is an important element for normal physiologic functions such as bone construction, nerve function, and muscle contraction. About 85% of phosphorus is stored in the bones and different tissues in the body. The excess phosphorus is eliminated from the body by the urinary system. The normal phosphate level in the blood is 3-4 mg/dL. Electrolytic disturbance resulting in high levels of phosphate in the blood causes hyperphosphatemia. Individuals with chronic kidney diseases have a decreased glomerular filtration rate and increased serum phosphate levels. The high phosphate levels in the serum lower calcium levels because of phosphate precipitation by calcium ions, leading to calcification of vascular tissues and heart diseases. Aluminum-, calcium-, magnesium-, and iron-based and aluminum-free, calcium-free phosphate binders are used to treat the condition.
Major factors driving the market include rise in prevalence of chronic diseases, high unmet medical needs, increase in the number of people undergoing dialysis, large geriatric population, and surge in public awareness worldwide. Diabetes and hypertension are the main causes of renal failure, which leads to hyperphosphatemia. However, stringent regulations by regulatory bodies such as the Food and Drug Administration (FDA), non-adherence to treatment regimens, and rise in side effects of hyperphosphatemia drugs are likely to inhibit the market. According to FDA use of hyperphosphatemia drugs for the treatment of high or low phosphorus levels in the human body is neither safe nor effective. High growth potential in untapped economies, such as India, China, South Africa, and Brazil, is expected to create lucrative opportunities for key players. Rise in geriatric population and increase in cases of osteoporosis in Asia Pacific is anticipated to drive the market. Osteoporosis is often undertreated and underdiagnosed, which is driving the hyperphosphatemia drugs market in Asia Pacific. The available calcium, lanthanum, sevelamer, and iron-based drugs for treating hyperphosphatemia are associated with certain side effects. The long-term use of calcium-based drugs such as calcium carbonate and calcium acetate can cause vascular calcification.
The Global Hyperphosphatemia Drugs Market had reached xxx million USD with a CAGR xx from 2018-2022. Later on, it will go to xxx million USD in 2023 with a CAGR xx % from 2023-2030.
In the global Hyperphosphatemia Drugs Market, This report focuses particularly in North America, South America, Europe and Asia-Pacific, and Middle East and Africa. This report classifies the Market on the basis of application, type, regions, and manufactures.
In Market segmentation by manufacturers, the report covers the following companies-
Keryx Biopharmaceuticals
Sanofi
Shire
Vifor Pharma
Amgen
Bayer
In Market segmentation by geographical regions, the report has analysed the following regions-
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
In Market segmentation by types :
Aluminum Phosphate Binder
Iron Phosphate Binder
Magnesium Phosphate Binder
Calcium Phosphate Binder
In Market segmentation by applications :
Hospitals
Clinics
Others
The research provides answers to the following key questions:
• What is the estimated growth rate and Market share and size of the Hyperphosphatemia Drugs Market for the forecast period 2023-2030?
• What are the driving forces in the Hyperphosphatemia Drugs Market for the forecast period 2023-2030?
• Who are the prominent Market players and how have they gained a competitive edge over other competitors?
• What are the Market trends influencing the progress of the Hyperphosphatemia Drugs industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the Market hold for the prominent Market players? Any special requirements about this report, please let us know and we can provide custom report.
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Hyperphosphatemia Drugs Market Size Growth Rate by Type (2020-2030)
1.3.2 Aluminum Phosphate Binder
1.3.3 Iron Phosphate Binder
1.3.4 Magnesium Phosphate Binder
1.3.5 Calcium Phosphate Binder
1.4 Market Segment by Application
1.4.1 Global Hyperphosphatemia Drugs Market Share by Application (2020-2030)
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hyperphosphatemia Drugs Market Size
2.1.1 Global Hyperphosphatemia Drugs Revenue 2015-2030
2.1.2 Global Hyperphosphatemia Drugs Sales 2015-2030
2.2 Hyperphosphatemia Drugs Growth Rate by Regions
2.2.1 Global Hyperphosphatemia Drugs Sales by Regions 2018 - 2022
2.2.2 Global Hyperphosphatemia Drugs Revenue by Regions 2018 - 2022
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Hyperphosphatemia Drugs Sales by Manufacturers
3.1.1 Hyperphosphatemia Drugs Sales by Manufacturers 2018 - 2022
3.1.2 Hyperphosphatemia Drugs Sales Market Share by Manufacturers 2018 - 2022
3.2 Revenue by Manufacturers
3.2.1 Hyperphosphatemia Drugs Revenue by Manufacturers (2018 - 2022)
3.2.2 Hyperphosphatemia Drugs Revenue Share by Manufacturers (2018 - 2022)
3.2.3 Global Hyperphosphatemia Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Hyperphosphatemia Drugs Price by Manufacturers
3.4 Key Manufacturers Hyperphosphatemia Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Hyperphosphatemia Drugs Market
3.6 Key Manufacturers Hyperphosphatemia Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Aluminum Phosphate Binder Sales and Revenue (2018 - 2022)
4.1.2 Iron Phosphate Binder Sales and Revenue (2018 - 2022)
4.1.3 Magnesium Phosphate Binder Sales and Revenue (2018 - 2022)
4.1.4 Calcium Phosphate Binder Sales and Revenue (2018 - 2022)
4.2 Global Hyperphosphatemia Drugs Sales Market Share by Type
4.3 Global Hyperphosphatemia Drugs Revenue Market Share by Type
4.4 Hyperphosphatemia Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Hyperphosphatemia Drugs Sales by Application
6 United States
6.1 United States Hyperphosphatemia Drugs Breakdown Data by Company
6.2 United States Hyperphosphatemia Drugs Breakdown Data by Type
6.3 United States Hyperphosphatemia Drugs Breakdown Data by Application
7 European Union
7.1 European Union Hyperphosphatemia Drugs Breakdown Data by Company
7.2 European Union Hyperphosphatemia Drugs Breakdown Data by Type
7.3 European Union Hyperphosphatemia Drugs Breakdown Data by Application
8 China
8.1 China Hyperphosphatemia Drugs Breakdown Data by Company
8.2 China Hyperphosphatemia Drugs Breakdown Data by Type
8.3 China Hyperphosphatemia Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Hyperphosphatemia Drugs Breakdown Data by Company
9.2 Rest of World Hyperphosphatemia Drugs Breakdown Data by Type
9.3 Rest of World Hyperphosphatemia Drugs Breakdown Data by Application
9.4 Rest of World Hyperphosphatemia Drugs Breakdown Data by Countries
9.4.1 Rest of World Hyperphosphatemia Drugs Sales by Countries
9.4.2 Rest of World Hyperphosphatemia Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Keryx Biopharmaceuticals
10.1.1 Keryx Biopharmaceuticals Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Hyperphosphatemia Drugs
10.1.4 Hyperphosphatemia Drugs Product Introduction
10.1.5 Keryx Biopharmaceuticals Recent Development
10.2 Sanofi
10.2.1 Sanofi Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Hyperphosphatemia Drugs
10.2.4 Hyperphosphatemia Drugs Product Introduction
10.2.5 Sanofi Recent Development
10.3 Shire
10.3.1 Shire Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Hyperphosphatemia Drugs
10.3.4 Hyperphosphatemia Drugs Product Introduction
10.3.5 Shire Recent Development
10.4 Vifor Pharma
10.4.1 Vifor Pharma Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Hyperphosphatemia Drugs
10.4.4 Hyperphosphatemia Drugs Product Introduction
10.4.5 Vifor Pharma Recent Development
10.5 Amgen
10.5.1 Amgen Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Hyperphosphatemia Drugs
10.5.4 Hyperphosphatemia Drugs Product Introduction
10.5.5 Amgen Recent Development
10.6 Bayer
10.6.1 Bayer Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Hyperphosphatemia Drugs
10.6.4 Hyperphosphatemia Drugs Product Introduction
10.6.5 Bayer Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Hyperphosphatemia Drugs Sales Channels
11.2.2 Hyperphosphatemia Drugs Distributors
11.3 Hyperphosphatemia Drugs Customers
12 Market Forecast
12.1 Global Hyperphosphatemia Drugs Sales and Revenue Forecast 2020-2030
12.2 Global Hyperphosphatemia Drugs Sales Forecast by Type
12.3 Global Hyperphosphatemia Drugs Sales Forecast by Application
12.4 Hyperphosphatemia Drugs Forecast by Regions
12.4.1 Global Hyperphosphatemia Drugs Sales Forecast by Regions 2020-2030
12.4.2 Global Hyperphosphatemia Drugs Revenue Forecast by Regions 2020-2030
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
Research Methodology
The Market Research Update offers technology-driven solutions and its full integration in the research process to be skilled at every step. We use diverse assets to produce the best results for our clients. The success of a research project is completely reliant on the research process adopted by the company. Market Research Update assists its clients to recognize opportunities by examining the global market and offering economic insights. We are proud of our extensive coverage that encompasses the understanding of numerous major industry domains.
Market Research Update provide consistency in our research report, also we provide on the part of the analysis of forecast across a gamut of coverage geographies and coverage. The research teams carry out primary and secondary research to implement and design the data collection procedure. The research team then analyzes data about the latest trends and major issues in reference to each industry and country. This helps to determine the anticipated market-related procedures in the future. The company offers technology-driven solutions and its full incorporation in the research method to be skilled at each step.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
We are flexible and responsive startup research firm. We adapt as your research requires change, with cost-effectiveness and highly researched report that larger companies can't match.
Information Safety
Market Research Update ensure that we deliver best reports. We care about the confidential and personal information quality, safety, of reports. We use Authorize secure payment process.
We Are Committed to Quality and Deadlines
We offer quality of reports within deadlines. We've worked hard to find the best ways to offer our customers results-oriented and process driven consulting services.
Our Remarkable Track Record
We concentrate on developing lasting and strong client relationship. At present, we hold numerous preferred relationships with industry leading firms that have relied on us constantly for their research requirements.
Best Service Assured
Buy reports from our executives that best suits your need and helps you stay ahead of the competition.
Customized Research Reports
Our research services are custom-made especially to you and your firm in order to discover practical growth recommendations and strategies. We don't stick to a one size fits all strategy. We appreciate that your business has particular research necessities.
Service Assurance
At Market Research Update, we are dedicated to offer the best probable recommendations and service to all our clients. You will be able to speak to experienced analyst who will be aware of your research requirements precisely.